Additional European Equity News

AstraZeneca (AZN LN) - Imfinzi plus Lynparza and Imfinzi alone both significantly improved progression-free survival in advanced endometrial cancer when added to chemotherapy. Elsewhere Ultomiris approved in Japan for the prevention of relapses in patients with neuromyelitis optica spectrum disorder (NMOSD). (AstraZeneca)

Atos (ATO FP) - US Court of Appeals has issued a favourable decision for Atos in the Trizetto litigation. (Newswires)

Credit Suisse (CSGN SW) - Co. has lost the Singapore case with a billionaire over fraud. (Newswires) 

Frasers (FRAS LN) - Put options sold by Ashley have been exercised and settled. (Frasers)

26 May 2023 - 07:30- Research Sheet- Source: Newsquawk

Subscribe Now to Newsquawk

Click here for a 1 week free trial

Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include: